Prognostic factors in patients with nonactive treatment of hepatocellular carcinoma;Factores pronósticos en pacientes con carcinoma hepatocelular desestimado para tratamiento

Gastroenterologia y Hepatologia

Volumn 30, Issue 8, 2007, Pages 441-448

  Sánchez, Antonio Díaz ^a   Martínez, Óscar Núñez ^a   Martín, Marisa Prieto ^a   Pedreño, Inmaculada Beceiro ^a   Kempin, Javier Calleja ^a   Castro, Leandro Santos ^a   De La Fuente, Avertano Muro ^a   Ricote, Gerardo Clemente ^a   Matilla Peña, Ana ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; METASTASIS; PORTAL VEIN THROMBOSIS; PREDICTION; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SEX DIFFERENCE; TUMOR VOLUME;

EID: 36049038592     PISSN: 02105705     EISSN: 15789519     Source Type: Journal    
DOI: 10.1157/13110488     Document Type: Article

References (17)

1. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology. 2003;37:429-42.
2. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693-9.
3. Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999; 19:329-38.
4. Rabe C, Pilz T, Klostermann C, Berna M, Schild HH, Sauerbruch T, et al. Clinical characteristics and outcome of a cohort of 101 patients with hepatocellular carcinoma. World J Gastroenterol. 2001;7:208-15.
5. Llovet JM, Bustamante J, Castells A, Vilana R, Ayuso MC, Sala M, et al. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology. 1999;29:62-7.
6. Nagasue N, Yukaya H, Hamada T, Hirose S, Kanashima R, Inokuchi K. The natural history of hepatocellular carcinoma. A study of 100 untreated cases. Cancer. 1984;54:1461-5.
7. Yeo W, Mo FKF, Chan ATC, Leung T, Hui P, Chan L, et al. La calidad de vida es predictiva de supervivencia en pacientes con carcinoma hepatocelular irresecable. Ann Oncol (ed. esp.). 2006;3:167-74.
8. Pawarode A, Voravud N, Sriuranpong V, Kullavanijaya P, Patt Y. Natural history of untreated primary hepatocellular carcinoma: a retrospective study of 157 patients. Am J Clin Oncol. 1998;21:386-91.
9. Sakar B, Ustuner Z, Karagol H, Aksu G, Camlica H, Faruk Aykan N. Prognostic features and survival of inoperable hepatocellular carcinoma in turkish patients with cirrhosis. Am J Clin Oncol. 2004;27:489-93.
10. Villa E, Moles A, Ferretti I, Buttafoco P, Grottola A, Del Buono M, et al. Natural history of inoperable hepatocellular carcinoma: estrogen receptors' status in the tumor is the strongest prognostic factor for survival. Hepatology. 2000;32:233-8.
11. Benvegnu L, Gios M, Pasin F, Di Nolfo A, Del Poggio P, Rapaccini G, et al. Natural history of untreated hepatocellular carcinoma on cirrhosis: survival analysis and prognostic factors in 559 patients. J Hepatol. 2006;44 Suppl 2:97.
12. Sutton FM, Russell NC, Guinee VF, Alpert E. Factors affecting the prognosis of primary liver carcinoma. J Clin Oncol. 1988; 6:321-8.
13. Yeung YP, Lo CM, Liu CL, Wong BC, Fan ST, Wong J. Natural history of untreated nonsurgical hepatocellular carcinoma. Am J Gastroenterol. 2005;100:1995-2004.
14. Calvet X, Bruix J, Gines P, Bru C, Sole M, Vilana R, et al. Prognostic factors of hepatocellular carcinoma in the west: a multivariate analysis in 206 patients. Hepatology. 1990;12:753-60.
15. Tangkijvanich P, Anukulkarnkusol N, Suwangool P, Lertmaharit S, Hanvivatvong O, Kullavanijaya P, et al. Clinical characteristics and prognosis of hepatocellular carcinoma: analysis based on serum alpha-fetoprotein levels. J Clin Gastroenterol. 2000;31:302-8.
16. Lerose R, Molinari R, Rocchi E, Manenti F, Villa E. Prognostic features and survival of hepatocellular carcinoma in Italy: impact of stage of disease. Eur J Cancer. 2001;37:239-45.
17. Villa E, Camellini L, Dugani A, Zucchi F, Grottola A, Merighi AL, et al. Variant estrogen receptor messenger RNA species detected in human primary hepatocellular carcinoma. Cancer Res. 1995;55:498-500.